Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2022   90,837,000        
Beginning balance at Dec. 31, 2022 $ 1,664,746 $ 908 $ 1,924,200 $ (285,474) $ (10,397) $ 35,509
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 24,598     24,106   492
Unrealized gain (loss) on available-for-sale securities and securitization assets 8,875       8,760 115
Unrealized gain (loss) on interest rate swaps (31,768)       (31,183) (585)
Issued shares of common stock (in shares)   763,000        
Issued shares of common stock 23,256 $ 8 23,248      
Equity-based compensation 7,898   774     7,124
Issuance (repurchase) of vested equity-based compensation shares (in shares)   58,000        
Issuance (repurchase) of vested equity-based compensation shares (1,317) $ 1 (1,318)      
Dividends and distributions (37,473)     (36,340)   (1,133)
Ending balance (in shares) at Mar. 31, 2023   91,658,000        
Ending balance at Mar. 31, 2023 1,658,815 $ 917 1,946,904 (297,708) (32,820) 41,522
Beginning balance (in shares) at Dec. 31, 2022   90,837,000        
Beginning balance at Dec. 31, 2022 1,664,746 $ 908 1,924,200 (285,474) (10,397) 35,509
Beginning balance (in shares) at Dec. 31, 2022   90,837,000        
Beginning balance at Dec. 31, 2022 $ 1,664,746 $ 908 1,924,200 (285,474) (10,397) 35,509
Ending balance (in shares) at Dec. 31, 2023 112,174,279 112,174,000        
Ending balance at Dec. 31, 2023 $ 2,141,625 $ 1,122 2,381,510 (303,536) 13,165 49,364
Beginning balance (in shares) at Mar. 31, 2023   91,658,000        
Beginning balance at Mar. 31, 2023 $ 1,658,815 $ 917 1,946,904 (297,708) (32,820) 41,522
Beginning balance (in shares) at Dec. 31, 2023 112,174,279 112,174,000        
Beginning balance at Dec. 31, 2023 $ 2,141,625 $ 1,122 2,381,510 (303,536) 13,165 49,364
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 124,548     123,025   1,523
Unrealized gain (loss) on available-for-sale securities and securitization assets (5,088)       (5,025) (63)
Unrealized gain (loss) on interest rate swaps 21,231       20,971 260
Issued shares of common stock (in shares)   1,293,000        
Issued shares of common stock 32,843 $ 13 32,830      
Equity-based compensation 6,602   936     5,666
Issuance (repurchase) of vested equity-based compensation shares (in shares)   9,000        
Issuance (repurchase) of vested equity-based compensation shares (158)   (158)      
Dividends and distributions $ (48,188)     (47,309)   (879)
Ending balance (in shares) at Mar. 31, 2024 113,475,576 113,476,000        
Ending balance at Mar. 31, 2024 $ 2,273,415 $ 1,135 $ 2,415,118 $ (227,820) $ 29,111 $ 55,871